HealthBeat: Managing Adult ADHD
WHOI, IL - 06 Dec 2002
... Researchers have been testing a new drug for ADHD, called Strattera™ (atomoxetine
hydrochloride, Eli Lilly and Co.). Strattera is a nonstimulant medication. ...

Nonstimulant Gets the OK
Newsday - 04 Dec 2002
... Atomoxetine, brand name Strattera, offers the same benefits as Ritalin and
other stimulants but works on a different set of brain chemicals called ...

Health Tips . . . from UPI
United Press International - 03 Dec 2002
... The drug, Strattera, (atomoxetine), has a different mechanism of action
from the stimulant-like drugs now used to treat ADHD. Because ...

New ADHD drug promises to calm children
KFOX, TX - 02 Dec 2002
... Strattera is the new drug that's proven to be effective in kids who
suffer from ADHD. Long term studies show Strattera works with ...

FDA Approves Three New Drugs
KMIZ, MO - 02 Dec 2002
There’s also a new drug for teens and adults with attention deficit hyperactivity
disorder. Strattera is not a stimulant under the Controlled Substances Act. ...

RISKS OF RITALIN
The Trentonian, NJ - 02 Dec 2002
... the Food and Drug Administration. It’s chemical name is atomoxetine
HC1, and will be marketed under the brand name Strattera.

Lilly's fortunes rise with OK of new drugs
South Bend Tribune, IN - 01 Dec 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

ADHD Drug; Seafood Risk?
WJAR, RI - 30 Nov 2002
... The drug, called Strattera, is approved for children and for the first time,
adults. It is unlike any of the current medications being used. ...

Business Digest
Long Beach Press-Telegram, CA - 29 Nov 2002
... Forteo, to treat osteoporosis, and Strattera, for attention deficit/hyperactivity
disorder, are expected to reach pharmacies within a few weeks.

Lilly ’ s fortunes improve
Johnson County Daily Journal, IN - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly’s
manufacturing issues with FDA, as the approvals would not have been ...

Lilly Stock Rises on OK of New Drugs
Times Daily, AL - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
Newsday - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
Lakeland Ledger, FL - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
WFTV, FL - 29 Nov 2002
... `We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
Austin American Statesman, TX - 29 Nov 2002
... `We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
ABC News - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
Seattle Post Intelligencer, WA - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
Sarasota Herald-Tribune, FL - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly Stock Rises on OK of New Drugs
Miami Herald, FL - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Lilly's fortunes rise on approval of new drugs, improved outlook
Miami Herald, FL - 29 Nov 2002
... We believe the approval of Forteo and Strattera signifies improvement with Lilly's
manufacturing issues with FDA, as the approvals would not have been likely ...

Footsie stands above 4200 level
Ananova, UK - 29 Nov 2002
... The broker lowered its target to 500p from 650p after Eli Lily on Tuesday gained
approval for Strattera, a competitor to Shire's Adderall attention deficit ...

FDA approves new drug for attention deficit disorder
Billings Gazette, MT - 28 Nov 2002
... The drug's chemical name is atomoxetine HC1 and it will be marketed by Eli
Lilly and Company of Indianapolis under the brand name Strattera. ...

UNMC tests help win approval of new attention drug
Henderson Gleaner, KY - 28 Nov 2002
UNMC was among several institutions to test the drug Strattera, developed
by Indianapolis-based Eli Lilly and Co. Strattera won ...

New attention deficit drug approved for sale in US
CBC News, Canada - 28 Nov 2002
The drug, atomoxetine HC1, will be marketed under the name Strattera.
Strattera is the first ADHD medication that will be exempt ...

FDA clears new drug to treat attention deficit hyperactivity
Newark Star Ledger, NJ - 28 Nov 2002
... The drug, called Strattera, is the first new class of medicine in three
decades to treat ADHD -- and the first that is not a stimulant. ...

Dow leaps 255 points, Nasdaq up 43
Baltimore Sun, MD - 28 Nov 2002
... The drug maker's Strattera is the first new medication for attention-deficit
and hyperactivity disorder to win approval in 30 years, the Food and Drug ...

Drug for attention deficit gets OK
Charlotte Observer, NC - 28 Nov 2002
... The drug's chemical name is atomoxetine HC1 and it will be marketed by
Eli Lilly and Co. of Indianapolis under the brand name Strattera. ...

New drug approved to treat ADHD
Roanoke Times, VA - 27 Nov 2002
... The drug's chemical name is atomoxetine HC1 and it will be marketed by
Eli Lilly and Co. of Indianapolis under the brand name Strattera.

FDA OKs new drug for ADHD patients
Richmond Times Dispatch, VA - 27 Nov 2002
... The drug's chemical name is atomoxetine HC1 and it will be marketed by Eli
Lilly and Company of Indianapolis under the brand name Strattera. ...

FDA Approval
WAKA, AL - 27 Nov 2002
... ALSO, THE FDA HAS APPROVED STRATTERA, THE FIRST NON- STIMULANT DRUG
FOR TREATING ATTENTION DEFICITE HYPERACTIVITY DISORDER OR ADHD. ...

Healthwatch - - Nov . 27
KLAS, NV - 27 Nov 2002
... Strattera works by blocking reabsorption of the brain chemical, norepinephrine,
which has a stimulating effect similar to adrenaline. READ MORE. ...

FDA approves Schering-Plough's Claritin as over-the-counter drug
Channel News Asia, Singapore - 27 Nov 2002
... The FDA has also approved Lilly's Strattera, which the agency said was the first
new drug in three decades for treating the symptoms of attention deficit ...

Wall Street soars 256 points as dealers take heart from data
The Scotsman, UK - 27 Nov 2002
... Eli Lilly jumped $5.15 to $69.15 after saying that it had received approval
from US regulators for Strattera, its drug for treating attention deficit ...

US statistics help turn FTSE positive
The Scotsman, UK - 27 Nov 2002
... Late on Tuesday, Eli Lilly said the US Food and Drug Administration had judged its
Strattera drug safe and effective for use by children, adolescents and adults ...

US shares surge ahead of Thanksgiving holiday
Channel News Asia, Singapore - 27 Nov 2002
... US$5.00 to US$69.00 following the Food and Drug Administration's approval of two
of its key drugs, its Forteo osteoporosis treatment as well as its Strattera ...

US Late Market Comment -5: Dollar General Drops
Yahoo Headlines - 27 Nov 2002
... Eli Lilly rose 7.8%, or 5, to 69 after receiving Food and Drug Administration
approval for its attention-deficit/hyperactivity disorder drug Strattera. ...

ADR Report-2: Chartered Semi's Rivals Up; Shire Pharm Dn
Yahoo Headlines - 27 Nov 2002
... Co. (LLY) got early US approval for Strattera, a treatment for attention-deficit
disorder that will compete with Shire's Adderall. ...

US Late Market Comment -4: EDS, Comverse Tech Advance
Yahoo Headlines - 27 Nov 2002
... Eli Lilly rose 7.8%, or 5, to 69 after receiving Food and Drug Administration
approval for its attention-deficit/hyperactivity disorder drug Strattera. ...

US Stats Bolster European Stocks
Smart Money - 27 Nov 2002
... 13% to 444 pence after US-based rival Eli Lilly received Food and Drug Administration
approval for its attention-deficit/hyperactivity disorder drug Strattera. ...

Non-Stimulant Approved for ADHD
WebMD - 27 Nov 2002
26, 2002 -- The FDA today approved Strattera, the first non-stimulant drug for treating
kids, teens, and adults with attention deficit hyperactivity disorder ...

US Late Market Comment -3: CNF, Coca-Cola Rise
Yahoo Headlines - 27 Nov 2002
... Eli Lilly rose 7.8%, or 5, to 69 after receiving Food and Drug Administration
approval for its attention-deficit/hyperactivity disorder drug Strattera. ...

Stocks Surge on Upbeat Data; Dow Industrials Gain 255.26, Nasdaq ...
Quicken - 27 Nov 2002
... And Eli Lilly rose 7.8% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera. Stocks climbed. ...

Stocks Surge on Upbeat Data; Dow Industrials Gain 255.26, Nasdaq ...
Quicken - 27 Nov 2002
... And Eli Lilly rose 7.8% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera. Stocks climbed. ...

Lilly Gains on Surprise Drug Approvals
ABC News - 27 Nov 2002
... After the market closed on Tuesday, the US Food and Drug Administration said
it had also given the nod to the company's Strattera -- the first attention ...

Claritin - Fish and Mercury - ADHD - Brittle Bones - Kidney ...
WLBT-TV, MS - 27 Nov 2002
... Strattera-O, was developed by Eli Lilly for people who have been diagnosed
with ADHD. The FDA has approved a new drug to help treat osteoporosis! ...

Battling osteoporosis
WTHR, IN - 27 Nov 2002
... Another Lilly drug receiving FDA approval is Strattera for attention deficit hyperactivity
disorder in children and adults. The drug comes in capsule form. ...

FDA Approves New ADHD Drug
WKRN, TN - 27 Nov 2002
... hyperactivity disorder. It's called Strattera, and it's the first ADHD
drug that's not defined as a stimulant under federal law. Therefore ...

ADR Report-ADRs gain on US data, Chartered soars
Forbes - 27 Nov 2002
... Lilly's Strattera is the only treatment for attention deficit approved by the US
Food and Drug Administration that is not a stimulant, making it a less likely ...

Stocks Hold Big Gains
The Gay Financial Network - 27 Nov 2002
... In the drug sector Eli Lilly (NYSE: LLY) received regulatory approval from the Food
and Drug Administration for its Strattera drug, a treatment for attention ...

FDA approves attention disorder drug
WTVW, IN - 27 Nov 2002
Indianapolis-based Eli Lilly expects Strattera to be available in pharmacies in
January. ADHD is one of the most common behavioral disorders of childhood. ...

Stocks Heading to Holiday Sharply Higher on Positive Economic ...
Quicken - 27 Nov 2002
... And Eli Lilly rose 7.6% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

Stocks Heading to Holiday Sharply Higher on Positive Economic ...
Quicken - 27 Nov 2002
... And Eli Lilly rose 7.6% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

Stocks Heading to Holiday Sharply Higher on Positive Economic ...
Quicken - 27 Nov 2002
... And Eli Lilly rose 7.6% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

ST Robinson Humphrey Boosts Lilly Rating
BusinessWeek - 27 Nov 2002
The US Food and Drug Administration approved Eli Lilly's (LLY ) Strattera
drug for attention-deficit/hyperactivity disorder. ST ...

Dow Industrials Up 256 Points at Midafternoon on Positive ...
Quicken - 27 Nov 2002
... And Eli Lilly rose 7.1% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

Dow Industrials Up 256 Points at Midafternoon on Positive ...
Quicken - 27 Nov 2002
... And Eli Lilly rose 7.1% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

European Stocks Close Higher, Boosted by US Data
Yahoo Headlines - 27 Nov 2002
... 13% to 444 pence after US-based rival Eli Lilly received Food and Drug Administration
approval for its attention-deficit/hyperactivity disorder drug Strattera. ...

Flurry of Economic Data Lifts Stocks in Early-Afternoon Trade
Yahoo Headlines - 27 Nov 2002
... And Eli Lilly rose 6.6% after it received FDA approval for its attention-deficit
and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

European Stocks Close Higher, Boosted by US Data
Quicken - 27 Nov 2002
... 13% to 444 pence after US-based rival Eli Lilly received Food and Drug Administration
approval for its attention-deficit/hyperactivity disorder drug Strattera. ...

European Stocks Close Higher, Boosted by US Data
Quicken - 27 Nov 2002
... 13% to 444 pence after US-based rival Eli Lilly received Food and Drug Administration
approval for its attention-deficit/hyperactivity disorder drug Strattera. ...

Flurry of Economic Data Lifts Stocks in Early-Afternoon Trade
Quicken - 27 Nov 2002
... And Eli Lilly rose 6.6% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

Flurry of Economic Data Lifts Stocks in Early-Afternoon Trade
Quicken - 27 Nov 2002
... And Eli Lilly rose 6.6% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

Flurry of Economic Data Lifts Stocks in Early-Afternoon Trade
Quicken - 27 Nov 2002
... And Eli Lilly rose 6.6% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks climbed. ...

FDA Approves New Drug for Attention Deficit Disorder
Santa Fe New Mexican, New Mexico - 27 Nov 2002
... The drug's chemical name is atomoxetine HC1 and it will be marketed by Eli
Lilly and Company of Indianapolis under the brand name Strattera. ...

Wall Street shares - Higher midday as economic data boost techs , ...
AFX Press - 27 Nov 2002
... The FDA yesterday approved Eli Lilly's Forteo osteoporosis treatment as well
as its Strattera drug for attention deficit hyperactivity disorder (ADHD). ...

Stock Rally Continues at Late Morning Amid Strong Economic Data
Yahoo Headlines - 27 Nov 2002
... And Eli Lilly rose 6.3% after it received FDA approval for its attention-deficit
and hyperactivity drug Strattera, and Novellus. Stocks rose. ...

Stocks Soar as Data Point to Recovery
ABC News - 27 Nov 2002
... jumped $4.35 to $68.35 after saying on Tuesday it received approval from US regulators
for Strattera, its drug for treating attention deficit hyperactivity ...

Stocks Soar as Data Point to Recovery
ABC News - 27 Nov 2002
... jumped $4.35 to $68.35 after saying on Tuesday it received approval from US regulators
for Strattera, its drug for treating attention deficit hyperactivity ...

US stocks soar as data point to economic recovery
Forbes - 27 Nov 2002
... Eli Lilly & Co. (nyse: LLY - news - people) jumped $4.35 to $68.35 after saying on
Tuesday it received approval from US regulators for Strattera, its drug for ...

Stocks Soar as Data Point to Recovery
Yahoo Headlines - 27 Nov 2002
... Eli Lilly & Co. (NYSE:LLY - News) jumped $4.35 to $68.35 after saying on Tuesday
it received approval from US regulators for Strattera, its drug for treating ...

Stocks Jump as Data Brightens Mood
ABC News - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Stocks Jump as Data Brightens Mood
ABC News - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Stocks Jump as Data Brightens Mood
Centre Daily Times, PA - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Stock Rally Continues at Late Morning Amid Strong Economic Data
Quicken - 27 Nov 2002
... And Eli Lilly rose 6.3% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks rose. ...

Stock Rally Continues at Late Morning Amid Strong Economic Data
Quicken - 27 Nov 2002
... And Eli Lilly rose 6.3% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks rose. ...

Stocks Jump as Data Brightens Mood
ABC News - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

US stocks jump as economic data brightens mood
Forbes - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Stocks Jump as Data Brightens Mood
Yahoo Headlines - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

FDA Approves Eli Lilly Drug for ADHD
WJXX, FL - 27 Nov 2002
... expects Strattera to be available in pharmacies in January. Lilly has tested
Strattera on more than 4000 patients, some for as long as 2 1/2 years. ...

Lilly Gains on Surprise Drug Approvals
ABC News - 27 Nov 2002
... After the market closed on Tuesday, the US Food and Drug Administration said it
had also approved the company's Strattera -- the first attention-deficit ...

Stocks Resume Rally at Midmorning Amid Flurry of Economic Data
Yahoo Headlines - 27 Nov 2002
... And Eli Lilly rose 4.3% after it received FDA approval for its attention-deficit
and hyperactivity drug Strattera, and Novellus. Stocks rose. ...

Lilly gains on surprise drug approvals
Forbes - 27 Nov 2002
... After the market closed on Tuesday, the US Food and Drug Administration said it
had also approved the company's Strattera -- the first attention-deficit ...

US Stocks Jump on Economic Optimism
Morningstar Canada, Canada - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Wall St prices expected to open higher
Ireland Online, Ireland - 27 Nov 2002
... The FDA approved Strattera, its attention-deficit and hyperactivity treatment
after giving approving Forteo, its osteoporosis drug earlier in the day. ...

Stocks Jump on Economic Optimism
Washington Post - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Hot Stocks: TKTX GENZ SHPGY LLY TQNT CHRT IBM OPWV
Yahoo Headlines - 27 Nov 2002
... .. ... ELI LILLY (LLY) Received FDA approval for its attention-deficit and hyperactivity
drug Strattera, which will compete directly with Shire's Adderall and ...

Stocks Resume Rally at Midmorning Amid Flurry of Economic Data
Quicken - 27 Nov 2002
... And Eli Lilly rose 4.3% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks rose. ...

Stocks Resume Rally at Midmorning Amid Flurry of Economic Data
Quicken - 27 Nov 2002
... And Eli Lilly rose 4.3% after it received FDA approval for its attention-
deficit and hyperactivity drug Strattera, and Novellus. Stocks rose. ...

BIOTECH STOCKS
CBS MarketWatch - 27 Nov 2002
... Late Tuesday, the drugmaker said that the US Food and Drug Administration has approved
Strattera, a therapy aimed at attention-deficit/hyperactivity disorder. ...

FDA Approves Lilly Drugs For ADHD, Osteoporosis
WRTV, IN - 27 Nov 2002
Lilly's new ADHD medication, Strattera, is the first non-stimulant
drug designed to treat the disorder. Lilly expects Strattera ...

US stocks jump on economic optimism
Forbes - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Stocks Jump on Economic Optimism
ABC News - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Lilly Attention-Deficit Drug Cleared by FDA
The Gay Financial Network - 27 Nov 2002
Eli Lilly (NYSE: LLY) received Food and Drug Administration clearance
to sell its attention-deficit hyperactivity treatment, Strattera. ...

Stocks Jump on Economic Optimism
Yahoo Headlines - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Attention disorder drug approved
CNN - 27 Nov 2002
... expects Strattera to be available in pharmacies in January. Lilly has tested
Strattera on more than 4000 patients, some for as long as 21/2 years. ...

US stocks jump on economic optimism
Yahoo Headlines - 27 Nov 2002
... $2.55 to $66.55 after saying on Tuesday it received approval from US regulators for
its drug for treating attention deficit hyperactivity disorder, Strattera. ...

Wall St prices expected to open higher
IrishExaminer.com, Ireland - 27 Nov 2002
... The FDA approved Strattera, its attention-deficit and hyperactivity treatment
after giving approving Forteo, its osteoporosis drug earlier in the day. ...

US Stocks on Track to Rise at Open; Techs Gain
Morningstar Canada, Canada - 27 Nov 2002
... from its close at $64 after saying Tuesday it received approval from US regulators
for its drug for treating attention deficit hyperactivity disorder, Strattera ...

Transkaryotic Set to Tumble
BusinessWeek - 27 Nov 2002
... S&P reiterates hold. Bank of America cut its estimates. The FDA approved Eli Lilly's
(LLY ) Strattera drug for attention-deficit/hyperactivity disorder. ...

FDA Approves ADHD Drug
KETV, NE - 27 Nov 2002
... disorder. It will sold under the name Strattera. It's the first ADHD
drug that's not defined as a stimulant under federal law. That ...